Venous thromboembolism and arterial thromboembolism. Many similarities, far beyond thrombosis per se

Walter Ageno; Francesco Dentali

doi:10.1160/TH08-06-0360

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2008; 100(02): 181-183
DOI: 10.1160/TH08-06-0360

Clinical Focus

Schattauer GmbH

Venous thromboembolism and arterial thromboembolism. Many similarities, far beyond thrombosis per se

Authors

Walter Ageno

¹Department of Clinical Medicine, University of Insubria, Varese, Italy
Francesco Dentali

¹Department of Clinical Medicine, University of Insubria, Varese, Italy

Abstract

Full Text

References

References
1 Agnelli G, Becattini C. Venous thromboembolism and atherosclerosis: common denominators or different diseases?. J Thromb Haemost 2006; 04: 1886-1890.
2 White RH. The epidemiology of venous thromboembolism. Circulation. 2003 107. I-4-I-8.
3 Prandoni P, Bilora F, Marchiori A. et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348: 1435-1441.
4 Becattini C, Agnelli G, Prandoni P. et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 2005; 26: 77-83.
5 Prandoni P, Ghirarduzzi A, Prins MH. et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 2006; 04: 1891-1896.
6 Schulman S, Lindmarker P, Holmstrom M. et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost 2006; 04: 734-742.
7 Bova C, Marchiori A, Noto A. et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost 2006; 96: 132-136.
8 Sørensen HT, Horvath-Puho E, Pedersen L. et al. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370: 1773-1779.
9 Reich LM, Folsom AR, Key NS. et al. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 2006; 04: 1909-1913.
10 van derHagen PB, Folsom AR, Jenny NS. et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 2006; 04: 1903-1908.
11 Hong C, Zhu F, Du D. et al. Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 2005; 183: 169-174.
12 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-1173.
13 Yusuf S, Hawken S, Ounpuu S. et al. on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet 2004; 364: 937-952.
14 Cines DB, Pollak ES, Buck CA. et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561.
15 Levine JS, Branch W, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
16 Homocysteine Studies Collaboration. Homocysteine and the risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002; 288: 2015-2022.
17 Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a metaanalysis of published epidemiological studies. J Thromb Haemost 2005; 03: 292-299.
18 Hansson PO, Eriksson H, Welin L. et al. Smoking and abdominal obesity: risk factors for venous throm-boembolism among middle-aged men: “the Study of Men Born in 1913”. Arch Intern Med 1999; 159: 1886-1890.
19 Samama MM. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 2000; 160: 3415-3420.
20 Petrauskiene V, Falk M, Waernbaum I. et al. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005; 48: 1017-1021.
21 Goldhaber SZ, Grodstein F, Stampfer MJ. et al. A prospective study of risk factors for pulmonary embolism in women. J Am MedAssoc 1997; 277: 642-645.
22 Vaya A, Mira Y, Ferrando F. et al. Hyperlipidemia and venous thromboembolism in patients lacking thrombophilic risk factors. Br J Haematol 2002; 118: 255-259.
23 Deguchi H, Pecheniuk NM, Elias DJ. et al. Highdensity lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation 2005; 112: 893-899.
24 Doggen CJM, Smith NL, Lemaitre RN. et al. Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol 2004; 24: 1970-1975.
25 Ageno W, Prandoni P, Romualdi E. et al. The metabolic syndrome and the risk of venous thrombosis. A prospective, case control study. J Thromb Haemost 2006; 04: 1914-1918.
26 Ay C, Tengler T, Vormittag R. et al. Venous thromboembolism--a manifestation of the metabolic syndrome. Haematologica 2007; 92: 374-380.
27 Ageno W, Becattini C, Brighton T. et al. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117: 93-102.
28 Pomp ER, Rosendaal FR, Doggen CJM. Smoking Increases the Risk of Venous Thrombosis. 2007 International Society on Thrombosis and Haemostasis Abstracts (P-T-546). XXI^st Congress of the International Society on Thrombosis and Haemostasis. Available at http://isth2007.abstractsondemand.com/